Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   A selective small-molecule nuclear factor-kappa B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits"
  2. Kang, M. I.; Henrich, C. J.; Bokesch, H. R.; Gustafson, K. R.; McMahon, J. B.; Baker, A. R.; Young, M. R.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2009 8(3): 571-581.
  1. 2.   Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors
  2. Shen, Q.; Uray, I. P.; Li, Y. X.; Zhang, Y.; Hill, J.; Xu, X. C.; Young, M. R.; Gunther, E. J.; Hilsenbeck, S. G.; Colburn, N. H.; Chodosh, L. A.; Brown, P. H.
  3. Cancer Prevention Research. 2008 1(1): 45-55.
  1. 3.   Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis
  2. Matthews, C. P.; Birkholz, A. M.; Baker, A. R.; Perella, C. M.; Becky, G. R.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2007, Mar; 67(6): 2430-2438.
  1. 4.   A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1
  2. Ruocco, K. M.; Goncharova, E. I.; Young, M. R.; Colburn, N. H.; McMahon, J. B.; Henrich, C. J.
  3. Journal of Biomolecular Screening. 2007, Feb; 12(1): 133-139.
  1. 5.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 6.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 7.   HIF-1 - An oxygen and metal responsive transcription factor
  2. Maxwell, P.; Salnikow, K.
  3. Cancer Biology & Therapy. 2004 3(1): 29-35.
  1. 8.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 9.   A dominant negative c-jun specifically blocks okadaic acid- induced skin tumor promotion
  2. Thompson, E. J.; MacGowan, J.; Young, M. R.; Colburn, N.; Bowden, G. T.
  3. Cancer Research. 2002 62(11): 3044-3047.
  1. 10.   Induced expression of dominant-negative c-jun downregulates NF kappa B and AP-1 target genes and suppresses tumor phenotype in human keratinocytes
  2. Li, J. J.; Cao, Y.; Young, M. R.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2000 29(3): 159-169.
  1. 11.   cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells
  2. Cmarik, J. L.; Hegamyer, G.; Gerrard, B.; Dean, M.; Colburn, N. H.
  3. Genomics. 2000 66(2): 204-212.
  1. 12.   Activator protein 1 (AP-1)- and nuclear factor kappa B (NF-kappa B)-dependent transcriptional events in carcinogenesis
  2. Hsu, T. C.; Young, M. R.; Cmarik, J.; Colburn, N. H.
  3. Free Radical Biology and Medicine. 2000 28(9): 1338-1348.
  1. 13.   Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells
  2. Pennie, W. D.; Hegamyer, G. A.; Young, M. R.; Colburn, N. H.
  3. Cell Growth and Differentiation. 1999 10(4): 279-286.
  1. 14.   Vanadate-induced activation of activator protein-1: role of reactive oxygen species
  2. Ding, M.; Li, J. J.; Leonard, S. S.; Ye, J. P.; Shi, X. L.; Colburn, N. H.; Castranova, V.; Vallyathan, V.
  3. Carcinogenesis. 1999 20(4): 663-668.
  1. 15.   Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation
  2. Jansen, A. P.; Colburn, N. H.; Verma, A. K.
  3. Oncogene. 1999 18(42): 5806-5813.
  1. 16.   Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
  2. Young, M. R.; Li, J. J.; Rincon, M.; Flavell, R. A.; Sathyanarayana, B. K.; Hunziker, R.; Colburn, N.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(17): 9827-9832.
  1. 17.   Shortage of Mitogen-Activated Protein Kinase Is Responsible For Resistance to Ap-1 Transactivation and Transformation in Mouse Jb6 Cells
  2. Huang, C. S.; Ma, W. Y.; Young, M. R.; Colburn, N.; Dong, Z. G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(1): 156-161.
  1. 18.   Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation
  2. Watts, R. G.; Huang, C. S.; Young, M. R.; Li, J. J.; Dong, Z. G.; Pennie, W. D.; Colburn, N. H.
  3. Oncogene. 1998 17(26): 3493-3498.
  1. 19.   Expression of Dominant Negative Jun Inhibits Elevated Ap-1 and Nf-Kappa-B Transactivation and Suppresses Anchorage Independent Growth of Hpv Immortalized Human Keratinocytes
  2. Li, J. J.; Rhim, J. S.; Schlegel, R.; Vousden, K. H.; Colburn, N. H.
  3. Oncogene. 1998 16(21): 2711-2721.
  1. 20.   Grafting Assay Distinguishes Promotion Sensitive From Promotion Resistant Jb6 Cells
  2. Strickl, J.; Sun, Y.; Dong, Z. G.; Colburn, N. H.
  3. Carcinogenesis. 1997 18(6): 1135-1138.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel